Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 2
This trial is looking at the short term effects of having a drug called AZD5363 before chemotherapy for breast cancer. The women taking part have breast cancer that is sensitive to the female hormone oestrogen ( or ER positive).
Recruitment start: 30 January 2014
Recruitment end: 30 December 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor J F R Robertson
AstraZeneca
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Tayside Clinical Trials Unit (TCTU)
University of Nottingham
This is Cancer Research UK trial number CRUKE/12/054.
Last reviewed: 30 Dec 2016
CRUK internal database number: 10566
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
